Molecular mechanisms of drug resistance and its reversal in cancer

M Kartal-Yandim, A Adan-Gokbulut… - Critical reviews in …, 2016 - Taylor & Francis
Chemotherapy is the main strategy for the treatment of cancer. However, the main problem
limiting the success of chemotherapy is the development of multidrug resistance. The …

Biologically active sphingolipids in cancer pathogenesis and treatment

B Ogretmen, YA Hannun - Nature Reviews Cancer, 2004 - nature.com
Biologically active sphingolipids have key roles in the regulation of several fundamental
biological processes that are integral to cancer pathogenesis. Recent significant progress in …

Cannabinoids: potential anticancer agents

M Guzman - Nature reviews cancer, 2003 - nature.com
Cannabinoids—the active components of Cannabis sativa and their derivatives—exert
palliative effects in cancer patients by preventing nausea, vomiting and pain and by …

Thematic Review Series: Sphingolipids. Biodiversity of sphingoid bases (“sphingosines”) and related amino alcohols

ST Pruett, A Bushnev, K Hagedorn, M Adiga… - Journal of lipid …, 2008 - ASBMB
" Sphingosin" was first described by JLW Thudichum in 1884 and structurally characterized
as 2S, 3R, 4E-2-aminooctadec-4-ene-1, 3-diol in 1947 by Herb Carter, who also proposed …

Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance

S Ponnusamy, M Meyers-Needham, CE Senkal… - Future …, 2010 - Taylor & Francis
Sphingolipids have emerged as bioeffector molecules, controlling various aspects of cell
growth and proliferation in cancer, which is becoming the deadliest disease in the world …

Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor

C Sánchez, ML de Ceballos, TG del Pulgar, D Rueda… - Cancer research, 2001 - AACR
The development of new therapeutic strategies is essential for the management of gliomas,
one of the most malignant forms of cancer. We have shown previously that the growth of the …

Raft ceramide in molecular medicine

E Gulbins, R Kolesnick - Oncogene, 2003 - nature.com
Ceramide, generated by the action of acid sphingomyelinase (ASM), has emerged as a
biochemical mediator of stimuli as diverse as ionizing radiation, chemotherapy, UVA light …

The therapeutic potential of modulating the ceramide/sphingomyelin pathway

R Kolesnick - The Journal of clinical investigation, 2002 - Am Soc Clin Investig
While ceramide has been proposed as a messenger for events as diverse as differentiation,
senescence, proliferation, and cell cycle arrest, a larger body of research has focused on its …

Retinoid therapy of high-risk neuroblastoma

CP Reynolds, KK Matthay, JG Villablanca, BJ Maurer - Cancer letters, 2003 - Elsevier
Retinoids are derivatives of vitamin A that include all trans-retinoic acid (ATRA), 13-cis-
retinoic acid,(13-cis-RA), and fenretinide (4-HPR). High levels of either ATRA or 13-cis-RA …

Targeting SphK1 as a new strategy against cancer

D Shida, K Takabe, D Kapitonov, S Milstien… - Current drug …, 2008 - ingentaconnect.com
Sphingolipid metabolites have emerged as critical players in a number of fundamental
biological processes. Among them, sphingosine-1-phosphate (S1P) promotes cell survival …